医学
发作性谵妄
褪黑素
随机对照试验
安慰剂
不利影响
麻醉
恶心
Pacu公司
临床试验
外科
内科学
七氟醚
替代医学
病理
作者
Anne Louise Damgaard,Lars Peter Kloster Andersen,Aksel Karl Georg Jensen,Hien Quoc,Janus Christian Jakobsen,Lars Broksø Holst,Lars S. Rasmussen,Arash Afshari
摘要
Abstract Background Emergence agitation and delirium in children remain a common clinical challenge in the post‐anesthetic care unit. Preoperative oral melatonin has been suggested as an effective preventive drug with a favorable safety profile. The oral bioavailability of melatonin, however, is low. Therefore, the MELA‐PAED trial aims to investigate the efficacy and safety of intraoperative intravenous melatonin for the prevention of emergence agitation in pediatric surgical patients. Methods MELA‐PAED is a randomized, double‐blind, parallel two‐arm, multi‐center, superiority trial comparing intravenous melatonin with placebo. Four hundred participants aged 1–6 years will be randomized 1:1 to either the intervention or placebo. The intervention consists of intravenous melatonin 0.15 mg/kg administered approximately 30 min before the end of surgery. Participants will be monitored in the post‐anesthetic care unit (PACU), and the Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ‐AS) will be performed on days 1, 7, and 14 after the intervention. Serious Adverse Events (SAE) will be assessed up to 30 days after the intervention. Results The primary outcome is the incidence of emergence agitation, assessed dichotomously as any Watcha score >2 during the participant's stay in the post‐anesthetic care unit. Secondary outcomes are opioid consumption in the post‐anesthetic care unit and adverse events. Exploratory outcomes include SAEs, postoperative pain, postoperative nausea and vomiting, and time to awakening, to first oral intake, and to discharge readiness. Conclusion The MELA‐PAED trial investigates the efficacy of intravenous intraoperative melatonin for the prevention of emergence agitation in pediatric surgical patients. Results may provide further knowledge concerning the use of melatonin in pediatric perioperative care.
科研通智能强力驱动
Strongly Powered by AbleSci AI